Varaico: Literature-Extracted Genetic Variants

Gene:ATP6V1B2
Variant:p.R506*
Back to variants list

ATP6V1B2

NM_001693.4:p.R506*

Associated Papers

Single Administration of AAV-mAtp6v1b2 Gene Therapy Rescues Hearing and Vestibular Disorders Caused by Atp6v1b2-Induced Lysosomal Dysfunction in Hair Cells.

Wei G et al.

Advanced Science (weinheim, Baden-wurttemberg, Germany), 2025

GDC: Integration of Multi-Omic and Phenotypic Resources to Unravel the Genetic Pathogenesis of Hearing Loss.

Cheng H et al.

Advanced Science (weinheim, Baden-wurttemberg, Germany), 2025

40089864 (PubMed )
Supplement: ADVS-12-2408891-s002.zip › TableS5_r2.xlsx › Sheet1

Clinical Insights into Bilateral Cochlear Implantation for a Child with Dominant Deafness-Onychodystrophy Syndrome.

Kao WT et al.

Journal of the American Academy of Audiology, 2025

Utilizing C. elegans Spermatogenesis and Fertilization Mutants as a Model for Human Disease.

Perez SM et al.

Journal of Developmental Biology, 2025

Epilepsy due to potential loss of ATP6V1B2 function with mechanistic insight by a Drosophila Vha55 model.

Sheng W et al.

Clinical Genetics, 2024

Dominantly acting variants in ATP6V1C1 and ATP6V1B2 cause a multisystem phenotypic spectrum by altering lysosomal and/or autophagosome function.

Carpentieri G et al.

Hgg Advances, 2024

V-ATPase Dysfunction in the Brain: Genetic Insights and Therapeutic Opportunities.

Falace A et al.

Cells, 2024

Deciphering potential causative factors for undiagnosed Waardenburg syndrome through multi-data integration.

Sun F et al.

Orphanet Journal of Rare Diseases, 2024

The ATP6V1B2 DDOD/DOORS-Associated p.Arg506* Variant Causes Hyperactivity and Seizures in Mice.

Rousseau J et al.

Genes, 2023

A novel pathogenic ATP6V1B2 variant: Widening the genotypic spectrum of the epileptic neurodevelopmental phenotype.

Veltra D et al.

American Journal of Medical Genetics. Part A, 2022

Genetic architecture and phenotypic landscape of deafness and onychodystrophy syndromes.

Gao X et al.

Human Genetics, 2022

Correspondence on "DOORS syndrome and a recurrent truncating ATP6V1B2 variant" by Beauregard-Lacroix et al.

Gao X et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2021

Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene.

Gao X et al.

Stem Cell Research, 2021

DOORS syndrome and a recurrent truncating ATP6V1B2 variant.

Beauregard-Lacroix E et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2021

Syndromic Deafness Gene ATP6V1B2 Controls Degeneration of Spiral Ganglion Neurons Through Modulating Proton Flux.

Qiu S et al.

Frontiers in Cell and Developmental Biology, 2021

Case Report: Exome Sequencing Identified Variants in Three Candidate Genes From Two Families With Hearing Loss, Onychodystrophy, and Epilepsy.

Li Y et al.

Frontiers in Genetics, 2021

Establishment of human induced pluripotent stem cell line (CPGHi002-A) from a 10-month-old female patient with DDOD syndrome carrying a heterozygous c.1516 C > T mutation in ATP6V1B2.

Gao X et al.

Stem Cell Research, 2020

ATP6V1B2-related epileptic encephalopathy.

Inuzuka LM et al.

Epileptic Disorders : International Epilepsy Journal With Videotape, 2020

Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the ATP6V1B2 Gene.

Zádori D et al.

Frontiers in Neurology, 2020

Genetic Epidemiology and Clinical Features of Hereditary Hearing Impairment in the Taiwanese Population.

Wu CC et al.

Genes, 2019

A subunit of V-ATPases, ATP6V1B2, underlies the pathology of intellectual disability.

Zhao W et al.

Ebiomedicine, 2019

Utility and limitations of exome sequencing as a genetic diagnostic tool for children with hearing loss.

Sheppard S et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2018

29907799 (PubMed )
Supplement: 41436_2018_4_MOESM3_ESM.xlsx › variant-_capture___coverage

Dominant deafness-onychodystrophy syndrome caused by an ATP6V1B2 mutation.

Menendez I et al.

Clinical Case Reports, 2017

Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome.

Kortüm F et al.

Nature Genetics, 2015

De novo mutation in ATP6V1B2 impairs lysosome acidification and causes dominant deafness-onychodystrophy syndrome.

Yuan Y et al.

Cell Research, 2014

Association of Genetic Variations in Energy Metabolism Genes with Noise-Induced Hearing Loss in a Chinese Population: A Case-Control Study.

Wang B et al.

Noise & Health, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."